These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 3149609)

  • 1. A protease-hypersensitive deletion derivative of human tissue-type plasminogen activator.
    Weidle UH; Buckel P; Mattes R
    Gene; 1988 Dec; 73(2):439-47. PubMed ID: 3149609
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Functional topology of human tissue-type plasminogen activator: characterization of two deletion derivatives and of a duplication derivative.
    Stern A; Mattes R; Buckel P; Weidle UH
    Gene; 1989 Jul; 79(2):333-44. PubMed ID: 2477307
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structural determinants of the noncatalytic chain of tissue-type plasminogen activator that modulate its association rate with plasminogen activator inhibitor-1.
    de Serrano VS; Castellino FJ
    J Biol Chem; 1990 Jun; 265(18):10473-8. PubMed ID: 2113057
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of a modified human tissue plasminogen activator comprising a kringle-2 and a protease domain.
    Burck PJ; Berg DH; Warrick MW; Berg DT; Walls JD; Jaskunas SR; Crisel RM; Weigel B; Vlahos CJ; McClure DB
    J Biol Chem; 1990 Mar; 265(9):5170-7. PubMed ID: 2108167
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biochemical and functional characterization of human tissue-type plasminogen activator variants obtained by deletion and/or duplication of structural/functional domains.
    Lijnen HR; Nelles L; Van Hoef B; De Cock F; Collen D
    J Biol Chem; 1990 Apr; 265(10):5677-83. PubMed ID: 2156824
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of domain deletion and/or duplication mutants of a recombinant chimera of tissue-type plasminogen activator and urokinase-type plasminogen activator (rt-PA/u-PA).
    Nelles L; Lijnen HR; Van Nuffelen A; Demarsin E; Collen D
    Thromb Haemost; 1990 Aug; 64(1):53-60. PubMed ID: 2148847
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effector roles of kringle 1 and kringle 2 in the enzymatic properties of recombinant tissue-type plasminogen activator as revealed by generation of recombinant molecules containing each kringle linked to the protease domain.
    Rydzewski A; Castellino FJ
    Arch Biochem Biophys; 1993 Jan; 300(1):472-82. PubMed ID: 8424682
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Kinetic characterization of tissue-type plasminogen activator (t-PA) and t-PA deletion mutants.
    de Vries C; Veerman H; Nesheim ME; Pannekoek H
    Thromb Haemost; 1991 Mar; 65(3):280-5. PubMed ID: 1904654
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Involvement of finger domain and kringle 2 domain of tissue-type plasminogen activator in fibrin binding and stimulation of activity by fibrin.
    Verheijen JH; Caspers MP; Chang GT; de Munk GA; Pouwels PH; Enger-Valk BE
    EMBO J; 1986 Dec; 5(13):3525-30. PubMed ID: 3030730
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Artificial exon shuffling between tissue-type plasminogen activator (t-PA) and urokinase (u-PA): a comparative study on the fibrinolytic properties of t-PA/u-PA hybrid proteins.
    de Vries C; Veerman H; Blasi F; Pannekoek H
    Biochemistry; 1988 Apr; 27(7):2565-72. PubMed ID: 3132969
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Autonomous functions of structural domains on human tissue-type plasminogen activator.
    van Zonneveld AJ; Veerman H; Pannekoek H
    Proc Natl Acad Sci U S A; 1986 Jul; 83(13):4670-4. PubMed ID: 3088564
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structure and function of human tissue-type plasminogen activator (t-PA).
    van Zonneveld AJ; Veerman H; MacDonald ME; van Mourik JA; Pannekoek H
    J Cell Biochem; 1986; 32(3):169-78. PubMed ID: 3097031
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Kringle 1 domain of human tissue-type plasminogen activator is a functional module mediating fibrinogen-stimulated plasminogenolytic activity.
    Stern A; Weidle UH
    Gene; 1990 Mar; 87(2):305-8. PubMed ID: 2158930
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structure-function analysis with tissue-type plasminogen activator. Effect of deletion of NH2-terminal domains on its biochemical and biological properties.
    Kalyan NK; Lee SG; Wilhelm J; Fu KP; Hum WT; Rappaport R; Hartzell RW; Urbano C; Hung PP
    J Biol Chem; 1988 Mar; 263(8):3971-8. PubMed ID: 3126183
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biological properties of hybrid plasminogen activators.
    Hung PP; Wilhelm J; Kalyan NK; Cheng SM; James HL; Nachowiak D; Weinheimer CJ; Sobel BE; Bergmann SR; Lee SG
    Adv Exp Med Biol; 1990; 281():201-8. PubMed ID: 2129369
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fibrin affinity and clearance of t-PA deletion and substitution analogues.
    Johannessen M; Diness V; Pingel K; Petersen LC; Rao D; Lioubin P; O'Hara P; Mulvihill E
    Thromb Haemost; 1990 Feb; 63(1):54-9. PubMed ID: 2111048
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of human tissue-type plasminogen activator variants with amino acid mutations in the kringle 1 domain.
    Ikenaka Y; Yajima K; Yahara H; Maruyama H; Matsumoto K; Okada K; Ueshima S; Matsuo O
    Blood Coagul Fibrinolysis; 1992 Aug; 3(4):381-7. PubMed ID: 1330023
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stimulation by fibrinogen of the amidolytic activity of single-chain tissue plasminogen activator.
    Urano T; deSerrano VS; Urano S; Castellino FJ
    Arch Biochem Biophys; 1989 Apr; 270(1):356-62. PubMed ID: 2494944
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tissue-type plasminogen activator mutants imitating urokinase in the peptide link between kringle and protease domains and at selected sites within the protease domain.
    Hinzmann B; Wernicke D; Pfeifer M; Zacharias U; Fischer B; Eisenmenger F; Will H
    Eur J Biochem; 1993 Apr; 213(1):437-43. PubMed ID: 8386628
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasmin-mediated fibrinolysis by variant recombinant tissue plasminogen activators.
    Urano S; Metzger AR; Castellino FJ
    Proc Natl Acad Sci U S A; 1989 Apr; 86(8):2568-71. PubMed ID: 2523073
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.